MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
Usefulness of Cardiac MIBG Scintigraphy, DAT scan and midbrain/pontine ratio to differentiate Parkinson disease from atypical parkinsonian syndrome

H. Fujita, K. Suzuki, Y. Watanabe, M. Hamaguchi, K. Hirata (Mibu, Japan)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease

L-A. Leyland, R. Mahmood, R. Weil (London, United Kingdom)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients

S. Becker, C. Pauly, M. Lawton, G. Hipp, F. Bowring, P. Sulzer, M. Hu, R. Krüger, I. Liepelt-Scarfone (Tübingen, Germany)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Validation of the ‘ecological momentary assessment’ (EMA) method as a tool for daily life monitoring in patients with Parkinson’s disease

J. Habets, M. Heijmans, C. Herff, C. Simons, A. Leentjens, Y. Temel, M. Kuijf, P. Kubben (Maastricht, Netherlands)

Phenomenology and Clinical Assessment of Movement Disorders  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Validation of the Seoul-instrumental activity daily living in the detection of dementia in Parkinson disease

SJ. Kim (Busan, Republic of Korea)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease

H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Vascular white matter involvement in Idiopathic Normal Pressure Hydrocephalus: association with cognitive and motor impairment

M. Todisco, P. Vitali, B. Minafra, F. Avantaggiato, R. Zangaglia, NG. Pozzi, R. Ceravolo, C. Pacchetti (Pavia, Italy)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity

S. Gutierrez, K. Aveni, A. Torani, A. Roberts (Evanston, IL, USA)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
VIM stimulation for refractory tremor -the Sheba experience

V. Livneh, S. Korn, G. Yaalom, T. Karmon, H. Strauss, Z. Zibly, R. Spiegelmann, S. Baer (Tel Aviv, Israel)

Surgical Therapy  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley